[{"AccountsPayableCurrent_0_Q2_USD":1334000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":0.0,"PaymentOfFinancingAndStockIssuanceCosts_2_Q2_USD":200000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-927000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-548000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-34000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":-65000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":-34000.0,"OtherAssetsNoncurrent_0_Q2_USD":90000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":139000.0,"OperatingIncomeLoss_2_Q2_USD":-39050000.0,"OperatingIncomeLoss_1_Q2_USD":-21569000.0,"PaymentsToAcquireInvestments_2_Q2_USD":201640000.0,"OperatingExpenses_2_Q2_USD":39050000.0,"NonoperatingIncomeExpense_2_Q2_USD":148000.0,"NonoperatingIncomeExpense_1_Q2_USD":124000.0,"NetIncomeLossAttributableToRedeemableNoncontrollingInterest_2_Q2_USD":0.0,"NetIncomeLossAttributableToRedeemableNoncontrollingInterest_1_Q2_USD":0.0,"NetIncomeLoss_2_Q2_USD":-38902000.0,"NetIncomeLoss_1_Q2_USD":-21445000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-30901000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-201675000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":35487000.0,"LongTermInvestments_0_Q2_USD":145136000.0,"LineOfCredit_0_Q2_USD":400000.0,"OperatingExpenses_1_Q2_USD":21569000.0,"LiabilitiesCurrent_0_Q2_USD":8323000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":35000.0,"PreferredStockSharesAuthorized_0_Q2_shares":200000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":43506825.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":43535887.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":139000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":495000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":361340000.0,"StockholdersEquity_0_Q2_USD":361340000.0,"ShortTermInvestments_0_Q2_USD":87017000.0,"ShareBasedCompensation_2_Q2_USD":6553000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-92231000.0,"RestrictedCashNoncurrent_0_Q2_USD":371000.0,"RestrictedCashAndInvestmentsCurrent_0_Q2_USD":35011000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ResearchAndDevelopmentExpense_2_Q2_USD":28908000.0,"RedeemableNoncontrollingInterestEquityCarryingAmount_0_Q2_USD":35000000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":286000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":402000.0,"ProfitLoss_2_Q2_USD":-38902000.0,"ProfitLoss_1_Q2_USD":-21445000.0,"ProceedsFromStockPlans_2_Q2_USD":495000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":139000.0,"ProceedsFromMinorityShareholders_2_Q2_USD":34853000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3761000.0,"PreferredStockValue_0_Q2_USD":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"ResearchAndDevelopmentExpense_1_Q2_USD":16242000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":43535887.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":404663000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":655000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-21479000.0,"CommonStockValue_0_Q2_USD":4000.0,"CommonStockSharesOutstanding_0_Q2_shares":43622745.0,"CommonStockSharesIssued_0_Q2_shares":43622745.0,"CommonStockSharesAuthorized_0_Q2_shares":1000000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommitmentsAndContingencies_0_Q2_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-197089000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":168373000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":132991000.0,"AssetsCurrent_0_Q2_USD":258780000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-38967000.0,"Assets_0_Q2_USD":404663000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":7954147.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":6553000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":3760000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1_Q2_USD":147000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3760000.0,"AdditionalPaidInCapital_0_Q2_USD":453641000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-74000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":116000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":228000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":6989000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-820000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":7954147.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":143000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q2_USD":0.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":-21479000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":674000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":695000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":716000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":424000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":246000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":3553000.0,"InvestmentIncomeInterest_2_Q2_USD":1075000.0,"InvestmentIncomeInterest_1_Q2_USD":672000.0,"IncreaseInCarryingAmountOfRedeemablePreferredStock_1_Q2_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":508000.0,"IncreaseDecreaseInAccountsReceivableRelatedParties_2_Q2_USD":0.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_Q2_USD":0.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":1019000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":5327000.0,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":-58000.0,"FairValueConcentrationOfRiskInvestments_0_Q2_USD":0.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":1556000.0,"EarningsPerShareDiluted_2_Q2_USD":-0.89,"EarningsPerShareDiluted_1_Q2_USD":-0.49,"EarningsPerShareBasic_2_Q2_USD":-0.89,"EarningsPerShareBasic_1_Q2_USD":-0.49,"DepreciationDepletionAndAmortization_2_Q2_USD":59000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q2_USD":0.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":-38967000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":10142000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":43506825.0,"Ticker":"KNTE","CIK":"1797768","name":"KINNATE BIOPHARMA INC.","OfficialName":"Kinnate Biopharma Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"393785585.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210816"}]